Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial


Ocvirk J., Brodowicz T., Wrba F., Ciuleanu T. E. , Kurteva G., Beslija S., ...More

WORLD JOURNAL OF GASTROENTEROLOGY, vol.16, no.25, pp.3133-3143, 2010 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 25
  • Publication Date: 2010
  • Doi Number: 10.3748/wjg.v16.i25.3133
  • Title of Journal : WORLD JOURNAL OF GASTROENTEROLOGY
  • Page Numbers: pp.3133-3143

Abstract

AIM: To investigate efficacy and safety of cetuximab combined with two chemotherapy regimens in patients with unresectable metastatic colorectal cancer (mCRC).